Biotecnol
Biotecnol is a private biopharmaceutical company specializing in immuno-oncology, developing antibody-based immunotherapies that activate and direct the patient's immune system to combat various cancers. The company aims to license or sell its products to pharmaceutical partners after achieving clinical proof of concept.
- Tb535 - T-cell engager Tribody™
- Immunotherapies for cancer treatment
Locations
Digital Popularity
Social Media
Competitors
ImmuPharma is a biopharmaceutical company that specializes in the usage and development of biopolymers, specifically peptides.
Virax Biolabs is dedicated to innovating immune resistance testing through the development of advanced immune profiling solutions and T-cell diagnostics.
Company Details
Biotecnol is operated by Biotecnol Limited and is a Active company incorporated on 18 September 2013 with the registered office located in London, City of London. Biotecnol Limited was registered 11 years ago.
Status
Active
Size
Micro
Directors
1
Age
11 years old
Employees
1
Turnover
Unreported
Total Assets
£21.85K
Cash in Bank
£21.85K
Total Liabilities
-£910